Literature summary for 2.3.1.81 extracted from

Atasoy, A.R.; Ciftci, I.H.; Petek, M.
Modifying enzymes related aminoglycoside: analyses of resistant Acinetobacter isolates (2015), Int. J. Clin. Exp. Med., 8, 2874-2880.

Search for more literature for 2.3.1.81

Cloned(Commentary)

Cloned (Comment)	Organism
gene aacC2, genotyping	Acinetobacter baumannii

Inhibitors

Inhibitors	Comment	Organism	Structure
additional information	determination of imipenem, meropenem, and gentamicin resistant clinical isolates	Acinetobacter baumannii

Natural Substrates/ Products (Substrates)

Natural Substrates	Organism	Comment (Nat. Sub.)	Natural Products	Comment (Nat. Pro.)	Rev.	Reac.
additional information	Acinetobacter baumannii	determination of imipenem, meropenem, and gentamicin resistant clinical isolates	?	-	?

Organism

Organism	UniProt	Comment	Textmining
Acinetobacter baumannii	P29807	gene aacC2; diverse clinical isolates, gene aacC2	-

Source Tissue

Source Tissue	Comment	Organism	Textmining
additional information	analysis of enzyme expression in several clinical isolates, overview	Acinetobacter baumannii	-

Substrates and Products (Substrate)

Substrates	Comment Substrates	Organism	Products	Comment (Products)	Rev.	Reac.
additional information	determination of imipenem, meropenem, and gentamicin resistant clinical isolates	Acinetobacter baumannii	?	-	?

Synonyms

Synonyms	Comment	Organism
aac3-Ia	-	Acinetobacter baumannii
aminoglycoside N(3)-acetyltransferase III	UniProt	Acinetobacter baumannii

General Information

General Information	Comment	Organism
additional information	presence of genes encoding the following aminoglycoside-modifying enzymes: aph (3')-V1, aph (3')-Ia, aac (3)-Ia, aac (3) IIa, aac (6')-Ih, aac (6')-Ib and ant (2')-Ia responsible for resistance in 4 different groups of clinical isolates, overview	Acinetobacter baumannii

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)